ASPET’s Division of Behavioral Pharmacology sponsors the P. B. Dews Award for Research in Behavioral Pharmacology.  The award, which is given biennially,  is supported by an endowment made possible by contributions from Aventis, Centre de Recherche Pierre Fabre, Eli Lilly, Harvard University, International Life Sciences Institute Caffeine Committee, Merck (San Diego), Pepsi Cola Company, Pfizer Central Research and Pfizer Global Research and Development, Pharmacia, Wyeth-Ayerst Research, and ASPET members.  The Award consists of $750, an appropriate plaque, and travel support for the winner to the award ceremony.  The purpose of this Award is to recognize outstanding lifetime achievements in research, teaching and professional service in the field of Behavioral Pharmacology and to honor Peter Dews for his seminal contributions to the development of behavioral pharmacology as a discipline. 

There are no restrictions on institutional affiliation and a candidate need not be a member of the Society.  Nominations may be made by members ASPET or of any relevant scientific society. 

Nominations shall be accompanied by:

1. Six copies of a description of the candidate’s major contributions, including scientific, teaching and professional achievements.  

2. Six copies of the candidate’s curriculum vitae.

3. Six copies of a list of the candidate’s list of publications and trainees.

4. Six copies of each of five major publications.

Selection of the recipient will be made by the P. B. Dews Award Committee, appointed by the President of ASPET.  The Award and plaque will be presented to the recipient at the annual meeting of ASPET.  The recipient will be invited by the Chair of the Division of Behavioral Pharmacology to deliver a special lecture on this occasion.  The lecture will be published subsequently in an appropriate, ASPET-sponsored publication. 

Nominations for this Award must be received no later than September 15 of the year before the award is to be presented by the Executive Officer, American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, Maryland 20814-3995.